GoHearing Ultra vs Otofonix Groove

The GoHearing Ultra is a budget-priced OTC behind-the-ear hearing aid that earned a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable tier of OTC devices, though its overall performance ranks 58th out of 65 OTC hearing aids tested. This device shows a distinctive performance profile with notable strengths in specific areas. Feedback handling earned an excellent 5.0/5, scoring 0.46 points above the category average—meaning users are unlikely to experience whistling or squealing during typical use. Music streaming also performed well at 3.6/5, a solid score that sits 1.68 points above the OTC average of 1.92/5, making it a reasonable choice for those who prioritize phone audio streaming. However, the GoHearing Ultra struggles in core speech understanding metrics. Speech in quiet scored just 1.0/5, falling 1.79 points below the category average, while speech in noise also scored 1.0/5, sitting 0.48 points below average. Own-voice comfort measured 1.9/5, which is 0.61 points below the typical OTC device. These low speech scores significantly limit the device's utility for its primary purpose of improving conversation clarity. Consumers seeking better overall value in this price range may want to consider alternatives like the Elehear Beyond (4.36/5) or Apple AirPods Pro 2 (4.06/5), which deliver substantially stronger speech performance. The GoHearing Ultra may suit buyers who prioritize streaming audio and feedback-free wear over speech enhancement, but those seeking meaningful speech benefit should explore higher-performing options.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.